Nuo Therapeutics, Inc.
AURX
$1.63
$0.00460.28%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 89.63% | 106.53% | 124.37% | 140.45% | 252.74% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 89.63% | 106.53% | 124.37% | 140.45% | 252.74% |
| Cost of Revenue | 121.36% | 124.41% | 140.13% | 164.68% | 321.36% |
| Gross Profit | 81.45% | 101.67% | 120.21% | 134.32% | 238.47% |
| SG&A Expenses | 16.42% | 2.67% | -3.58% | -12.34% | -8.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.37% | 8.00% | 1.22% | -7.99% | -4.41% |
| Operating Income | 3.31% | 17.49% | 22.43% | 28.70% | 25.23% |
| Income Before Tax | 8.24% | 21.93% | 26.73% | 28.68% | 25.20% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.24% | 21.93% | 26.73% | 28.68% | 25.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.24% | 21.93% | 26.73% | 28.68% | 25.20% |
| EBIT | 3.31% | 17.49% | 22.43% | 28.70% | 25.23% |
| EBITDA | 4.78% | 18.23% | 22.78% | 28.85% | 25.37% |
| EPS Basic | 14.79% | 27.89% | 32.05% | 32.49% | 28.09% |
| Normalized Basic EPS | 10.03% | 23.48% | 28.03% | 32.24% | 27.96% |
| EPS Diluted | 14.79% | 27.89% | 32.05% | 32.49% | 28.09% |
| Normalized Diluted EPS | 10.03% | 23.48% | 28.03% | 32.24% | 27.96% |
| Average Basic Shares Outstanding | 7.38% | 7.91% | 7.95% | 5.68% | 4.24% |
| Average Diluted Shares Outstanding | 7.38% | 7.91% | 7.95% | 5.68% | 4.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |